Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: A randomized, controlled study

American Journal of Gastroenterology

Volumn 103, Issue 10, 2008, Pages 2509-2516

  Bossa, Fabrizio ^a   Latiano, Anna ^a   Rossi, Luigia ^b   Magnani, Mauro ^b   Palmieri, Orazio ^a   Dallapiccola, Bruno ^c   Serafini, Sonja ^b   Damonte, Gianluca ^d   De Santo, Ermelinda ^a   Andriulli, Angelo ^a   Annese, Vito ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; DEXAMETHASONE; INFLIXIMAB; MESALAZINE; PREDNISOLONE;

ACNE; ADULT; AGED; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; ENCAPSULATION; ERYTHROCYTE; FEMALE; HIRSUTISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSOMNIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ULCERATIVE COLITIS; WEIGHT GAIN;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLONOSCOPY; DEXAMETHASONE; DRUG CARRIERS; DRUG RESISTANCE; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MESALAMINE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 53149124013     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02103.x     Document Type: Article

References (22)

1. Kornbluth A, Sachar DB. Ulcerative practice guidelines in adults (update): American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2004 99 : 1371 85.
2. Lichtenstein GR, Abreu MT, Cohen T, et al. For the American Gastroenterological Association. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006 130 : 940 87.
3. Clark M, Colombel JF, Feagan BC, et al. American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology 2007 133 : 312 39.
4. Faubion WA, Loftus EV, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study. Gastroenterology 2001 121 : 255 60.
5. Yang YX, Lichtenstein GR. Corticosteroids in Crohn's disease. Am J Gastroenterol 2002 97 : 803 23.
6. ® Capsules). A review of its therapeutic use in the management of active Crohn's disease in adults. Drugs 2002 62 : 2263 82.
7. Rizzello F, Gionchetti P, D'Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: A double-blind placebo-controlled study. Aliment Pharmacol Ther 2002 16 : 1109 16.
8. Naber AHJ, Olaison G, Smedh, et al. Pharmacokinetics of budesonide: Controlled ileal release capsule in active Crohn's disease. Gastroenterology 1996 110 (Suppl 1 977A.
9. Magnani M, Rossi L, D'Ascenzo M, et al. Erythrocyte engineering for drug delivery and targeting. Biotechnol Appl Biochem 1998 28 : 1 6.
10. D'Ascenzo M, Antonelli A, Chiarantini L, et al. Red blood cells as a glucocorticoids delivery system. In : Sprandel U, Way JL, eds. Erythrocytes as drug carriers in medicine. New York, NY : Plenum Press, 1997 : 81 8.
11. Rossi L, Serafini S, Generini L, et al. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease. Biotechnol Appl Biochem 2001 33 : 85 9.
12. Rossi L, Castro M, D'Orio F, et al. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow progression of lung disease in cystic fibrosis patients. Blood Cells Mol Dis 2004 33 : 57 63.
13. Annese V, Latiano A, Rossi L, et al. Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - a pilot uncontrolled study. Am J Gastroenterol 2005 100 : 1370 5.
14. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
15. Powell-Tuck J, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978 13 : 833 7.
16. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964 1 : 89 92.
17. Higgins PD, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 2005 54 : 782 8.
18. Damonte G, Salis A, Rossi L, et al. High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma. J Pharm Biomed Anal 2007 43 : 376 80.
19. Hoffman JF. On red blood cells, hemolysis and resealed ghost. In : Magnani M, DeLoach JR, eds. The use of resealed erythrocytes as carriers and bioreactors. New York : Plenum, 1992 : 1 15.
20. Castro M, Rossi L, Papadatou B, et al. Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn's disease. J Pediatr Gastroenterol Nutr 2007 44 : 423 6.
21. Schimmer BP, Parker KL. Adrenocorticotropin hormone. In : Schimmer BP, Parker KL. Adrenocorticotropin hormone. In : Goodman LS, Limbird LE, Milinoff PB, and Ruddon RW. Goodman & Gilman's The pharmacological basis of therapeutics, 9th Ed. New York, NY : Mc Graw-Hill, 1996 : 1458 85.
22. Crinelli R, Antonelli A, Bianchi M, et al. Selective inhibition of NF-kappaB activation and TNF-alfa production in macrophages by red blood cell-mediates delivery of dexamethasone. Blood Cells Mol Dis 2000 26 : 211 22.